Cite

HARVARD Citation

    Donelson, J. et al. (2019). Cardiac‐specific ablation of glutaredoxin 3 leads to cardiac hypertrophy and heart failure. Physiological reports. 7 (8), p. n/a. [Online]. 
  
Back to record